» Articles » PMID: 18218899

Centromeric Aurora-B Activation Requires TD-60, Microtubules, and Substrate Priming Phosphorylation

Overview
Journal Science
Specialty Science
Date 2008 Jan 26
PMID 18218899
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

The chromosome passenger complex (CPC) controls chromosome congression, kinetochore-microtubule attachments, and spindle checkpoint signaling during mitosis. Aurora-B kinase is the catalytic subunit of the CPC. To understand how a single kinase can regulate such diverse events, we have investigated the activation of Aurora-B and describe two distinct activation mechanisms. First, Aurora-B activation in vitro requires two cofactors, telophase disc-60kD (TD-60) and microtubules. TD-60 is critical to localize both the CPC and Haspin kinase activity to centromeres and thus regulates Aurora-B at several levels. Second, Aurora-B substrates can inhibit kinase activation, and this is relieved by phosphorylation of these substrates by the centromeric kinases Plk1 and Haspin. These regulatory mechanisms suggest models for phosphorylation by Aurora-B of centromeric substrates at unaligned chromosomes and merotelic attachments.

Citing Articles

Inhibition of glutathione peroxidase 4 suppresses gastric cancer peritoneal metastasis via regulation of RCC2 homeostasis.

Hu C, Xu J, Zhang Y, Zhang R, Pan S, Chen J Redox Biol. 2025; 80:103519.

PMID: 39908861 PMC: 11847474. DOI: 10.1016/j.redox.2025.103519.


NudCL2 is required for cytokinesis by stabilizing RCC2 with Hsp90 at the midbody.

Xu X, Huang Y, Yang F, Sun X, Lin R, Feng J Protein Cell. 2024; 15(10):766-782.

PMID: 38801297 PMC: 11443449. DOI: 10.1093/procel/pwae025.


Increased Aurora B expression reduces substrate phosphorylation and induces chromosomal instability.

Britigan E, Wan J, Sam D, Copeland S, Lasek A, Hrycyniak L Front Cell Dev Biol. 2022; 10:1018161.

PMID: 36313574 PMC: 9606593. DOI: 10.3389/fcell.2022.1018161.


A Number of the N-terminal RASSF Family: RASSF7.

Xu Y, Du W, Xiao Y, Gao K, Li J, Li S Anticancer Agents Med Chem. 2022; 24(12):889-895.

PMID: 36200241 DOI: 10.2174/1871520622666220930094149.


Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor.

Tran T, Vu L, Nguyen H, Pham H, Do X, Than U Int J Mol Med. 2022; 50(5).

PMID: 36102296 PMC: 9558763. DOI: 10.3892/ijmm.2022.5189.